Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1988 5
1989 3
1990 4
1991 1
1992 1
1993 2
1994 1
1995 1
1997 1
2000 1
2001 2
2002 2
2003 1
2004 3
2005 9
2006 9
2007 8
2008 7
2009 12
2010 13
2011 15
2012 13
2013 13
2014 13
2015 10
2016 5
2017 7
2018 5
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

142 results
Results by year
Filters applied: . Clear all
Page 1
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M. van Assen S, et al. Among authors: geborek p. Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3. Ann Rheum Dis. 2011. PMID: 21131643
Swedish registers to examine drug safety and clinical issues in RA.
Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, Lindblad S, Klareskog L. Askling J, et al. Among authors: geborek p. Ann Rheum Dis. 2006 Jun;65(6):707-12. doi: 10.1136/ard.2005.045872. Epub 2006 Jan 13. Ann Rheum Dis. 2006. PMID: 16414975 Free PMC article. Review.
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.
van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M. van Assen S, et al. Among authors: geborek p. Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20. Autoimmun Rev. 2011. PMID: 21182987 Review.
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
Kristensen LE, Jakobsen AK, Bartels EM, Geborek P, Bliddal H, Saxne T, Danneskiold-Samsøe B, Christensen R. Kristensen LE, et al. Among authors: geborek p. Scand J Rheumatol. 2011 Jan;40(1):1-7. doi: 10.3109/03009742.2010.491834. Epub 2010 Oct 15. Scand J Rheumatol. 2011. PMID: 20950126 Review.
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsøe B, Saxne T. Kristensen LE, et al. Among authors: geborek p. Scand J Rheumatol. 2007 Nov-Dec;36(6):411-7. doi: 10.1080/03009740701607067. Scand J Rheumatol. 2007. PMID: 18092260 Review.
142 results